Royce & Associates’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-256,725
| Closed | -$965K | – | 1248 |
|
|
2018
Q2 | $965K | Hold |
256,725
| – | – | 0.01% | 950 |
|
|
2018
Q1 | $1.05M | Hold |
256,725
| – | – | 0.01% | 961 |
|
|
2017
Q4 | $1.19M | Hold |
256,725
| – | – | 0.01% | 942 |
|
|
2017
Q3 | $1.82M | Hold |
256,725
| – | – | 0.01% | 856 |
|
|
2017
Q2 | $1.86M | Hold |
256,725
| – | – | 0.01% | 861 |
|
|
2017
Q1 | $1.58M | Hold |
256,725
| – | – | 0.01% | 913 |
|
|
2016
Q4 | $1.5M | Sell |
256,725
-61,000
| -19% | -$357K | 0.01% | 877 |
|
|
2016
Q3 | $1.69M | Sell |
317,725
-134,000
| -30% | -$711K | 0.01% | 844 |
|
|
2016
Q2 | $2.99M | Hold |
451,725
| – | – | 0.02% | 730 |
|
|
2016
Q1 | $2.11M | Buy |
451,725
+110,000
| +32% | +$514K | 0.01% | 813 |
|
|
2015
Q4 | $1.73M | Buy |
+341,725
| New | +$1.73M | 0.01% | 879 |
|